Dai ichi Life Insurance Company Ltd Sells 46 Shares of Axon Enterprise, Inc. (NASDAQ:AXON)

Dai ichi Life Insurance Company Ltd decreased its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 2.0% during the second quarter, according to the company in its most recent filing with the SEC. The fund owned 2,228 shares of the biotechnology company’s stock after selling 46 shares during the period. Dai ichi Life Insurance Company Ltd’s holdings in Axon Enterprise were worth $656,000 as of its most recent filing with the SEC.

Other institutional investors have also made changes to their positions in the company. CoreCap Advisors LLC acquired a new stake in Axon Enterprise in the 2nd quarter valued at approximately $592,000. Federated Hermes Inc. raised its position in shares of Axon Enterprise by 14.5% during the second quarter. Federated Hermes Inc. now owns 234,185 shares of the biotechnology company’s stock valued at $68,907,000 after buying an additional 29,680 shares during the last quarter. Prevail Innovative Wealth Advisors LLC lifted its position in Axon Enterprise by 19.8% in the second quarter. Prevail Innovative Wealth Advisors LLC now owns 6,552 shares of the biotechnology company’s stock worth $1,928,000 after purchasing an additional 1,085 shares during the period. DekaBank Deutsche Girozentrale boosted its stake in Axon Enterprise by 32.2% during the second quarter. DekaBank Deutsche Girozentrale now owns 22,450 shares of the biotechnology company’s stock worth $6,689,000 after buying an additional 5,464 shares in the last quarter. Finally, Nicholas Investment Partners LP increased its holdings in Axon Enterprise by 76.0% in the 2nd quarter. Nicholas Investment Partners LP now owns 3,054 shares of the biotechnology company’s stock valued at $899,000 after buying an additional 1,319 shares during the period. 79.08% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, President Joshua Isner sold 25,811 shares of Axon Enterprise stock in a transaction that occurred on Tuesday, September 10th. The shares were sold at an average price of $359.84, for a total value of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares in the company, valued at approximately $82,103,253.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In related news, CEO Patrick W. Smith sold 80,300 shares of the company’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $371.78, for a total value of $29,853,934.00. Following the transaction, the chief executive officer now directly owns 3,015,366 shares in the company, valued at $1,121,052,771.48. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, President Joshua Isner sold 25,811 shares of the business’s stock in a transaction that occurred on Tuesday, September 10th. The stock was sold at an average price of $359.84, for a total transaction of $9,287,830.24. Following the completion of the transaction, the president now directly owns 228,166 shares of the company’s stock, valued at approximately $82,103,253.44. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 316,981 shares of company stock valued at $115,281,744. Insiders own 6.10% of the company’s stock.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $385.77 on Tuesday. The firm has a market capitalization of $29.15 billion, a PE ratio of 112.80, a price-to-earnings-growth ratio of 10.30 and a beta of 0.94. The company has a quick ratio of 2.52, a current ratio of 2.88 and a debt-to-equity ratio of 0.35. Axon Enterprise, Inc. has a twelve month low of $189.12 and a twelve month high of $386.54. The stock’s 50-day simple moving average is $340.58 and its 200 day simple moving average is $315.24.

Axon Enterprise (NASDAQ:AXON) last issued its quarterly earnings results on Tuesday, August 6th. The biotechnology company reported $1.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.02 by $0.18. The firm had revenue of $504.00 million for the quarter, compared to the consensus estimate of $478.35 million. Axon Enterprise had a net margin of 16.06% and a return on equity of 9.34%. The company’s revenue for the quarter was up 34.5% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.80 EPS. On average, analysts anticipate that Axon Enterprise, Inc. will post 1.79 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on the company. JMP Securities upped their price target on Axon Enterprise from $375.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, September 12th. Needham & Company LLC reaffirmed a “buy” rating and issued a $400.00 price target on shares of Axon Enterprise in a report on Wednesday, August 7th. Craig Hallum upped their price objective on Axon Enterprise from $370.00 to $376.00 and gave the stock a “buy” rating in a report on Wednesday, August 7th. Northland Securities boosted their price target on shares of Axon Enterprise from $330.00 to $365.00 and gave the stock an “outperform” rating in a research note on Thursday, August 8th. Finally, Barclays raised their target price on Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the company. According to data from MarketBeat.com, Axon Enterprise currently has a consensus rating of “Moderate Buy” and an average price target of $365.38.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.